BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants
Yang Liu, Jianying Liu, Hongjie Xia, Xianwen Zhang, Jing Zou, Camila R. Fontes-Garfias, Scott C. Weaver, Kena A. Swanson, Hui Cai, Ritu Sarkar, Wei Chen, Mark Cutler, David Cooper, Alexander Muik, Uğur Şahin, Kathrin U. Jansen, Xuping Xie, Philip R. Dormitzer, Pei‐Yong Shi
Abstract
BNT162b2 Vaccine and Emerging SARS-CoV-2 Variants A total of 20 serum samples from 15 persons who received the BNT162b2 vaccine showed strong neutralization activity against recombinant viruses eng...
Topics & Concepts
NeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Spike ProteinCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyRecombinant DNAMedicineBiologyVirusGeneticsGeneOutbreakInfectious disease (medical specialty)DiseasePathologySARS-CoV-2 and COVID-19 ResearchBacillus and Francisella bacterial researchViral gastroenteritis research and epidemiology